In published reports, two different prevalence rates at birth of the skeletal dysplasias can be found: 4-7/10 000 reported by Gustavson and Jorulf,' and a lower figure of 2 4/10 000 given by Camera and Mastroiacovo.2 The latter authors stated that their figure should be closer to reality due to the larger size of their birth sample, which was obtained through a multicentre, hospital based programme.
The study presented here aimed to analyse the birth prevalence rates for the skeletal dysplasias, and to estimate its under-ascertainment, using the material of another multi-hospital birth 1983 period, when the previous 1967 to 1977 period is also considered (one case of spondyloepiphyseal dysplasia and one of asphyxiating thoracic dysplasia), several specific diagnoses were not registered at all. Kniest dysplasia, first described in 1952, metatropic dysplasia, known since 1966, the Majewski short rib-polydactyly syndrome, described in 1971, or the related Saldino-Noonan syndrome, described in 1972, are some of the types of skeletal dysplasia that should have been present in this material and were not.'( This is another aspect of the above mentioned continuous and incomplete process of knowledge on the subject of the skeletal dysplasias.
Another indication of under-registration can be seen from the fact that all cases of achondroplasia, the best known of all skeletal dysplasias, were diagnosed in only five of the 26 maternity hospitals involved. The 1.49/10 000 rate in these five hospitals is a similar prevalence rate for achondroplasia to the 0-67 reported by Gustavson and Jorulf,l and probably a more accurate one than the 0.46 rate obtained from the total ECLAMC sample or the 0-37 reported by Camera and Mastroiacovo.2 Since these five hospitals do not differ from the remaining sample with respect to parental ages or other demographic features that could explain a true higher frequency of achondroplasia, we can estimate that at least 36 cases of achondroplasia are missing among the 241 749 births that occurred in the other 21 hospitals. Such an estimate would raise the prevalence rate of all skeletal dysplasias to 3-29/ 10 000 births.
There is a recognised tendency to over-register achondroplasia, mostly due to the misdiagnosis of cases of thanatophoric dysplasia and achondrogenesis," which could also be seen in the material presented here. Forty-one percent of all cases (33/80) were originally diagnosed as achondroplasia, while less than half of them (14/33) were still diagnosed as such after revision of the documentation.
Those cases diagnosed as achondroplasia by the paediatrician, in which radiological documentation was insufficient, were placed into one of the non-specific diagnostic groups in order to keep them apart from the wholly unspecified skeletal dysplasia cases, where not even achondroplasia was suggested as a probable diagnosis by the attending paediatrician. The group of questionable achondroplasia with death in the perinatal period is likely to include cases with thanatophoric dysplasia and achondrogenesis, as was the case with those few patients with available x-ray films and'photographs. On the other hand, the questionable achondroplasia group surviving the perinatal period could very well include some cases of true achondroplasia. However, this could not be substantiated by the analysis of paternal ages, which were not raised as would be expected if most cases within this group were actually achondroplasia.
The calculated mutation rates must be affected by the over-as well as by the under-registration of achondroplasia. Much The lack of radiological data, follow up, and information on natural history does not allow a better sub-classification of cases in the osteogenesis imperfecta group. The observed 40% of perinatal mortality among them suggests that there is less than 40% of the 'lethal' type, since some cases of the 'severe' type are also expected to die in the perinatal period. 13 Furthermore, if all 33 cases with osteogenesis imperfecta diagnosed during the longer period 1967 to 1983 in the ECLAMC programme are considered, two families are included with an autosomal dominant pedigree and four with a family history typical of autosomal recessive inheritance. This observation, with only 10% (4/33) of the osteogenesis imperfecta cases attributable to an autosomal recessive trait, agrees with the discovery of new biochemical types of autosomal dominant inheritance among the more severe cases of osteogenesis imperfecta.13 14 This work was partially supported by the National 
